Reactivation of Desensitized Formyl Peptide Receptors by Platelet Activating Factor: A Novel Receptor Cross Talk Mechanism Regulating Neutrophil Superoxide Anion Production

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Forsman, Huamei ^a   Önnheim, Karin ^a   Andréasson, Emil ^a   Christenson, Karin ^a   Karlsson, Anna ^a   Bylund, Johan ^a   Dahlgren, Claes ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CALCIUM; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; FORMYLPEPTIDE RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; INTERLEUKIN 8; LATRUNCULIN A; PHOSPHATASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; THROMBOCYTE ACTIVATING FACTOR;

ACTIN FILAMENT; ACTIN POLYMERIZATION; ARTICLE; CALCIUM MOBILIZATION; CONTROLLED STUDY; DESENSITIZATION; MOLECULAR INTERACTION; NEUTROPHIL;

ACTINS; AZEPINES; BICYCLO COMPOUNDS, HETEROCYCLIC; CALCIUM; CELLS, CULTURED; CYCLOSPORINE; CYTOCHALASIN B; CYTOSKELETON; GELSOLIN; HUMANS; NADPH OXIDASE; NEUTROPHILS; OLIGOPEPTIDES; OXAZOLES; PEPTIDE FRAGMENTS; PLATELET ACTIVATING FACTOR; RECEPTORS, FORMYL PEPTIDE; SUPEROXIDES; THIAZOLIDINES; TRIAZOLES;

EID: 84875514441     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060169     Document Type: Article

References (52)

1. Luttrell LM, (2006) Transmembrane signaling by G protein-coupled receptors. Methods in molecular biology 332: 3-49.
2. Magalhaes AC, Dunn H, Ferguson SS (2011) Regulation of G Protein-Coupled Receptor Activity, Trafficking and Localization by Gpcr-Interacting Proteins. British journal of pharmacology.
3. Giniatullin R, Nistri A, Yakel JL, (2005) Desensitization of nicotinic ACh receptors: shaping cholinergic signaling. Trends in neurosciences 28: 371-378.
4. Hendriks-Balk MC, Peters SL, Michel MC, Alewijnse AE, (2008) Regulation of G protein-coupled receptor signalling: focus on the cardiovascular system and regulator of G protein signalling proteins. European journal of pharmacology 585: 278-291.
5. Kendall RT, Luttrell LM, (2009) Diversity in arrestin function. Cellular and molecular life sciences: CMLS 66: 2953-2973.
6. Vroon A, Heijnen CJ, Kavelaars A, (2006) GRKs and arrestins: regulators of migration and inflammation. Journal of leukocyte biology 80: 1214-1221.
7. Kenakin T, (2010) G protein coupled receptors as allosteric proteins and the role of allosteric modulators. Journal of receptor and signal transduction research 30: 313-321.
8. Rajagopal S, Rajagopal K, Lefkowitz RJ, (2010) Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nature reviews Drug discovery 9: 373-386.
9. Mundell SJ, Luo J, Benovic JL, Conley PB, Poole AW, (2006) Distinct clathrin-coated pits sort different G protein-coupled receptor cargo. Traffic 7: 1420-1431.
10. Potter RM, Maestas DC, Cimino DF, Prossnitz ER, (2006) Regulation of N-formyl peptide receptor signaling and trafficking by individual carboxyl-terminal serine and threonine residues. Journal of immunology 176: 5418-5425.
11. Peeters MC, van Westen GJ, Li Q, AP IJ, (2011) Importance of the extracellular loops in G protein-coupled receptors for ligand recognition and receptor activation. Trends in pharmacological sciences 32: 35-42.
12. Urwyler S, (2011) Allosteric modulation of family C G-protein-coupled receptors: from molecular insights to therapeutic perspectives. Pharmacological reviews 63: 59-126.
13. Fu H, Karlsson J, Bylund J, Movitz C, Karlsson A, et al. (2006) Ligand recognition and activation of formyl peptide receptors in neutrophils. J Leukoc Biol 79: 247-256.
14. Ye RD, Boulay F, Wang JM, Dahlgren C, Gerard C, et al. (2009) International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev 61: 119-161.
15. Forsman H, Onnheim K, Andreasson E, Dahlgren C (2011) WHAT FORMYL PEPTIDE RECEPTORS, IF ANY, ARE TRIGGERED BY COMPOUND 43 AND LIPOXIN A(4)? Scand J Immunol.
16. Huet E, Boulay F, Barral S, Rabiet MJ, (2007) The role of beta-arrestins in the formyl peptide receptor-like 1 internalization and signaling. Cellular signalling 19: 1939-1948.
17. Bylund J, Bjorstad A, Granfeldt D, Karlsson A, Woschnagg C, et al. (2003) Reactivation of formyl peptide receptors triggers the neutrophil NADPH-oxidase but not a transient rise in intracellular calcium. J Biol Chem 278: 30578-30586.
18. Klotz KN, Jesaitis AJ, (1994) Neutrophil chemoattractant receptors and the membrane skeleton. BioEssays: news and reviews in molecular, cellular and developmental biology 16: 193-198.
19. Omann GM, Swann WN, Oades ZG, Parkos CA, Jesaitis AJ, et al. (1987) N-formylpeptide-receptor dynamics, cytoskeletal activation, and intracellular calcium response in human neutrophil cytoplasts. Journal of immunology 139: 3447-3455.
20. Shenoy SK, Lefkowitz RJ (2011) beta-arrestin-mediated receptor trafficking and signal transduction. Trends in pharmacological sciences.
21. Bylund J, MacDonald KL, Brown KL, Mydel P, Collins LV, et al. (2007) Enhanced inflammatory responses of chronic granulomatous disease leukocytes involve ROS-independent activation of NF-kappa B. European journal of immunology. 37: 1087-1096.
22. Segal BH, Grimm MJ, Khan AN, Han W, Blackwell TS, (2012) Regulation of innate immunity by NADPH oxidase. Free radical biology & medicine 53: 72-80.
23. Segal BH, Veys P, Malech H, Cowan MJ, (2011) Chronic granulomatous disease: lessons from a rare disorder. Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation 17: S123-131.
24. McDonald B, Pittman K, Menezes GB, Hirota SA, Slaba I, et al. (2010) Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 330: 362-366.
25. Powell WS, Rokach J, (2005) Biochemistry, biology and chemistry of the 5-lipoxygenase product 5-oxo-ETE. Progress in lipid research 44: 154-183.
26. Stephens L, Milne L, Hawkins P, (2008) Moving towards a better understanding of chemotaxis. Current biology: CB 18: R485-494.
27. Wymann MP, Sozzani S, Altruda F, Mantovani A, Hirsch E, (2000) Lipids on the move: phosphoinositide 3-kinases in leukocyte function. Immunology today 21: 260-264.
28. Heit B, Tavener S, Raharjo E, Kubes P, (2002) An intracellular signaling hierarchy determines direction of migration in opposing chemotactic gradients. The Journal of cell biology 159: 91-102.
29. Fu H, Bylund J, Karlsson A, Pellme S, Dahlgren C, (2004) The mechanism for activation of the neutrophil NADPH-oxidase by the peptides formyl-Met-Leu-Phe and Trp-Lys-Tyr-Met-Val-Met differs from that for interleukin-8. Immunology 112: 201-210.
30. Ali H, Richardson RM, Haribabu B, Snyderman R, (1999) Chemoattractant receptor cross-desensitization. The Journal of biological chemistry 274: 6027-6030.
31. Didsbury JR, Uhing RJ, Tomhave E, Gerard C, Gerard N, et al. (1991) Receptor class desensitization of leukocyte chemoattractant receptors. Proceedings of the National Academy of Sciences of the United States of America 88: 11564-11568.
32. Harbecke O, Liu L, Karlsson A, Dahlgren C, (1997) Desensitization of the fMLP-induced NADPH-oxidase response in human neutrophils is lacking in okadaic acid-treated cells. Journal of leukocyte biology 61: 753-758.
33. Liu L, Harbecke O, Elwing H, Follin P, Karlsson A, et al. (1998) Desensitization of formyl peptide receptors is abolished in calcium ionophore-primed neutrophils: an association of the ligand-receptor complex to the cytoskeleton is not required for a rapid termination of the NADPH-oxidase response. J Immunol 160: 2463-2468.
34. Tomhave ED, Richardson RM, Didsbury JR, Menard L, Snyderman R, et al. (1994) Cross-desensitization of receptors for peptide chemoattractants. Characterization of a new form of leukocyte regulation. Journal of immunology 153: 3267-3275.
35. Richardson RM, Haribabu B, Ali H, Snyderman R, (1996) Cross-desensitization among receptors for platelet activating factor and peptide chemoattractants. Evidence for independent regulatory pathways. The Journal of biological chemistry 271: 28717-28724.
36. Boyum A, Lovhaug D, Tresland L, Nordlie EM, (1991) Separation of leucocytes: improved cell purity by fine adjustments of gradient medium density and osmolality. Scandinavian journal of immunology 34: 697-712.
37. Dahlgren C, Karlsson A, Bylund J, (2007) Measurement of respiratory burst products generated by professional phagocytes. Methods Mol Biol 412: 349-363.
38. Lundqvist H, Dahlgren C, (1996) Isoluminol-enhanced chemiluminescence: a sensitive method to study the release of superoxide anion from human neutrophils. Free radical biology & medicine 20: 785-792.
39. Karlsson J, Bylund J, Movitz C, Bjorkman L, Forsman H, et al. (2010) A methodological approach to studies of desensitization of the formyl peptide receptor: Role of the read out system, reactive oxygen species and the specific agonist used to trigger neutrophils. J Immunol Methods 352: 45-53.
40. Jones SA, Wolf M, Qin S, Mackay CR, Baggiolini M, (1996) Different functions for the interleukin 8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxidase and phospholipase D are activated through IL-8R1 but not IL-8R2. Proceedings of the National Academy of Sciences of the United States of America 93: 6682-6686.
41. Lundqvist H, Gustafsson M, Johansson A, Sarndahl E, Dahlgren C, (1994) Neutrophil control of formylmethionyl-leucyl-phenylalanine induced mobilization of secretory vesicles and NADPH-oxidase activation: effect of an association of the ligand-receptor complex to the cytoskeleton. Biochimica et biophysica acta 1224: 43-50.
42. Welch EJ, Naikawadi RP, Li Z, Lin P, Ishii S, et al. (2009) Opposing effects of platelet-activating factor and lyso-platelet-activating factor on neutrophil and platelet activation. Molecular pharmacology 75: 227-234.
43. Garcia RC, Whitaker M, Heyworth PG, Segal AW, (1992) Okadaic acid produces changes in phosphorylation and translocation of proteins and in intracellular calcium in human neutrophils. Relationship with the activation of the NADPH oxidase by different stimuli. The Biochemical journal 286 (Pt 3): 687-692.
44. Yarmola EG, Somasundaram T, Boring TA, Spector I, Bubb MR, (2000) Actin-latrunculin A structure and function. Differential modulation of actin-binding protein function by latrunculin A. The Journal of biological chemistry 275: 28120-28127.
45. Jesaitis AJ, Tolley JO, Allen RA, (1986) Receptor-cytoskeleton interactions and membrane traffic may regulate chemoattractant-induced superoxide production in human granulocytes. The Journal of biological chemistry 261: 13662-13669.
46. Vazquez-Prado J, Casas-Gonzalez P, Garcia-Sainz JA, (2003) G protein-coupled receptor cross-talk: pivotal roles of protein phosphorylation and protein-protein interactions. Cellular signalling 15: 549-557.
47. Jesaitis AJ, Klotz KN, (1993) Cytoskeletal regulation of chemotactic receptors: molecular complexation of N-formyl peptide receptors with G proteins and actin. European journal of haematology 51: 288-293.
48. Potter RM, Maestas DC, Cimino DF, Prossnitz ER, (2006) Regulation of N-formyl peptide receptor signaling and trafficking by individual carboxyl-terminal serine and threonine residues. J Immunol 176: 5418-5425.
49. Ali H, Richardson RM, Tomhave ED, Didsbury JR, Snyderman R, (1993) Differences in phosphorylation of formylpeptide and C5a chemoattractant receptors correlate with differences in desensitization. The Journal of biological chemistry 268: 24247-24254.
50. Tardif M, Mery L, Brouchon L, Boulay F, (1993) Agonist-dependent phosphorylation of N-formylpeptide and activation peptide from the fifth component of C (C5a) chemoattractant receptors in differentiated HL60 cells. Journal of immunology 150: 3534-3545.
51. DeFea KA, (2011) Beta-arrestins as regulators of signal termination and transduction: how do they determine what to scaffold? Cellular signalling 23: 621-629.
52. Min J, Defea K, (2011) beta-arrestin-dependent actin reorganization: bringing the right players together at the leading edge. Molecular pharmacology 80: 760-768.